| 000 | 01858 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515164602.0 | ||
| 264 | 0 | _c20090803 | |
| 008 | 200908s 0 0 eng d | ||
| 022 | _a1365-2141 | ||
| 024 | 7 |
_a10.1111/j.1365-2141.2009.07678.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJi, Min | |
| 245 | 0 | 0 |
_aSimultaneous targeting of MCL1 and ABCB1 as a novel strategy to overcome drug resistance in human leukaemia. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cJun 2009 |
||
| 300 |
_a648-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBlotting, Western _xmethods |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia _xdrug therapy |
| 650 | 0 | 4 | _aMyeloid Cell Leukemia Sequence 1 Protein |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
| 650 | 0 | 4 |
_aReverse Transcriptase Polymerase Chain Reaction _xmethods |
| 650 | 0 | 4 |
_aTransfection _xmethods |
| 700 | 1 | _aLi, Jie | |
| 700 | 1 | _aYu, Haiqing | |
| 700 | 1 | _aMa, Daoxin | |
| 700 | 1 | _aYe, Jingjing | |
| 700 | 1 | _aSun, Xiulian | |
| 700 | 1 | _aJi, Chunyan | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 145 _gno. 5 _gp. 648-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2141.2009.07678.x _zAvailable from publisher's website |
| 999 |
_c18779698 _d18779698 |
||